One percent of the clinical dose used for antenatal steroid therapy is sufficient to induce lung maturation when administered directly to the preterm ovine fetus
- 1 June 2022
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 322 (6) , L853-L865
Abstract
Antenatal steroids (ANSs) are routinely administered to women judged to be at imminent risk of preterm delivery. Their principal benefit is precocious functional maturation of the preterm fetal lung. Current dosing regimens expose the mother and fetus to high steroid levels that may be unnecessary, increasing the potential risks of disruption to the maternal and fetal hypothalamic-pituitary-adrenal (HPA) axis and glucose regulation, alterations in placental function, and reduced fetal growth. Using a sheep model of pregnancy, we tested the hypothesis that direct fetal administration of an ultra-low dose course of betamethasone phosphate (∼0.33 mg) would be sufficient to elicit functional maturation of the fetal lung. A jugular catheter was installed in singleton ovine fetuses at 122-day gestation under general anesthesia. Animals were randomized to receive either: 1) fetal intravenous betamethasone phosphate to target fetal plasma betamethasone mean levels of 2 ng/mL for 26 h (fetal treatment group; n = 16); 2) fetal intravenous saline for 26 h and two maternal intramuscular injections of 0.25 mg/kg betamethasone phosphate + betamethasone acetate, simulating a standard clinical treatment (maternal treatment group; n = 12); or 3) fetal intravenous saline only for 26 h (negative control group; n = 10). Fetuses were delivered 48 h after surgery, ventilated for 30 min to allow the collection of lung function and physiological data, and euthanized. Quantitative PCR and Western blots were used to assess markers of lung maturation. The average total betamethasone phosphate dose for the fetal treatment group was 1% (0.3 mg) of the maternal treatment group (31-mg betamethasone phosphate + betamethasone acetate). At 30 min of ventilation, arterial , pH, heart rate, and ventilation efficacy index (VEI) were significantly (P < 0.05) and equivalently improved in both the fetal treatment group and maternal treatment group, relative to the negative control group. Similarly, SP-A, SP-C, and AQ-5 mRNA expression was significantly higher in both the fetal treatment group and maternal treatment group, relative to negative control. Maternal steroid administration was not required to generate preterm fetal lung maturation in sheep. Using a low dose and targeting steroid treatments directly to the fetus has the potential to significantly reduce maternal exposures, while simultaneously reducing the potential risk of adverse outcomes associated with current clinical dosing regimens.
Keywords
Funding Information
- Stan Perron Charitable Foundation
- Channel 7 Telethon Trust
- Women and Infants Research Foundation (N/A)
This publication has 37 references indexed in Scilit:
- Multiple Courses of Antenatal Corticosteroids for Preterm Birth StudyJAMA Pediatrics, 2013
- Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial)Archives of Disease in Childhood - Fetal and Neonatal Edition, 2013
- School outcome, cognitive functioning, and behaviour problems in moderate and late preterm children and adults: A reviewSeminars in Fetal and Neonatal Medicine, 2012
- Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestationJournal of Perinatology, 2009
- Intramuscular Fetal Corticosteroid Therapy: Short-Term Effects on the FetusFetal Diagnosis and Therapy, 2009
- Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trialBMJ, 2005
- Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trialBMJ, 2005
- BETAMETHASONE PHARMACOKINETICS AFTER TWO PRODRUG FORMULATIONS IN SHEEP: IMPLICATIONS FOR ANTENATAL CORTICOSTEROID USEDrug Metabolism and Disposition, 2005
- Lung Surfactant Replacement in Premature Lambs with Extracted Lipids from Bovine Lung Lavage: Effects of Dose, Dispersion Technique, and Gestational AgePediatric Research, 1985
- PREMATURE DELIVERY OF FOETAL LAMBS INFUSED WITH GLUCOCORTICOIDSJournal of Endocrinology, 1969